ebook Munafa Stock Market Course + Intraday & FNO calls  

       

PPLPHARMA 185 CE (CALL) 27 January 2026 options price chart analysis Piramal Pharma Limited

Live Options price premium & chart analysis for PPLPHARMA 185 CE (CALL) 27 January 2026 options price chart analysis Piramal Pharma Limited

Piramal Pharma Limited PPLPHARMA trades in NSE under NSE

PPLPHARMA 185 CE Live prices

What is premium price of PPLPHARMA 185 CE CALL today?
Premium of PPLPHARMA 185 CE is 2.30 on 26 Dec 2025 CALL opened at 3.32 and traded inside a Low-High range of 2.21-3.49 today. Please click here table for more current prices.
What is open interest of PPLPHARMA 185 CALL CE today?
Open Interest of PPLPHARMA 185 CE is 220500 today. This has changed 26250.00 from previous day.
What is underlying price of PPLPHARMA 185 CE CALL today?
Underlying price of PPLPHARMA 185 CE CALL is 174.20 today.
What is lot size of PPLPHARMA 185 CALL CE today?
Lot size of PPLPHARMA 185 CALL CE is 2625.00
Is PPLPHARMA 185 CE CALL ITM or OTM or ATM?
PPLPHARMA 185 CALL CE is OTM CALL option (out of the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Underlying equity prev closing: 174.22

PPLPHARMA CALL CE available options strikes

CE 170, CE 175, CE 180, All CE , All PE

PPLPHARMA 185 CALL CE available expiry dates

30 Dec 202527 Jan 202624 Feb 2026

Premium of PPLPHARMA 185 CALL CE January 27 2026

PPLPHARMA 185 CE Live prices

Premium of CALL (CE) of strike 185 is at: 2.30 on 26 Dec 2025
CALL opened at 3.32 and traded inside a Low-High range of 2.21-3.49 as on 26 Fri Dec 2025

The underlying equity is trading at 174.22 which means that CALL of strike 185 is OTM CALL option (out of the money)

Lot size of PPLPHARMA Piramal Pharma Limited is 2625

Total Open Interest for CALL (CE) of strike 185 is 220,500

Munafa analysis PPLPHARMA 185 CE might not be profitable for buyers to buy this CALL, but this could be a good opportunity for sellers to make a quick profit.

Price action analysis of 185 CALL based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

Price action analysis of 185 CALL based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Click here to view most profitable CE and PE for Piramal Pharma Limited, both for buyers and sellers | PPLPHARMA Most Active Call Put Options

Date Underlying price CE price CE open CE high CE low CE volume CE OI OI Change
26 Fri Dec 174.22 2.30 3.32 3.49 2.21 -30 578,812,500 13.5%
24 Wed Dec 177.31 3.32 4.81 4.82 3.19 -3 509,906,250 45.1%
23 Tue Dec 178.01 3.43 3.62 4.36 3.43 -15 351,421,875 75.9%
22 Mon Dec 177.70 4.05 3.11 4.48 3.11 68 199,828,125 93.3%
19 Fri Dec 171.28 2.40 2.00 2.40 1.82 -91 103,359,375 -%
18 Thu Dec 166.52 29.35 0.00 0.00 0.00 0 0 -%

Charts for PPLPHARMA 185 CALL CE options for Piramal Pharma Limited

Select an expiry and a strike price below to view charts for those options. PPLPHARMA All in One charts

Charts for:      

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

PPLPHARMA 185 CE (CALL) 27 January 2026 options price chart analysis Piramal Pharma Limited

PPLPHARMA further analysis

PPLPHARMA 185 CE (CALL) 27 January 2026 options price chart analysis Piramal Pharma Limited

These are PPLPHARMA 185 CE (CALL) 27 January 2026 options price chart analysis Piramal Pharma Limited . Click the links below to switch between charts

 

Videos related to: PPLPHARMA 185 CE (CALL) 27 January 2026 options price chart analysis Piramal Pharma Limited

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

PPLPHARMA 185 CE (CALL) 27 January 2026 options price chart analysis Piramal Pharma Limited

 

Back to top